Clinical Trial Update: Post-transplantation Cyclophosphamide for Haploidentical Transplant From Maternal or Collateral Donors [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating post-transplant cyclophosphamide for haploidentical hematopoietic stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematopoietic Stem Cell Transplantation

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Hematopoietic Stem Cell Transplantation | Phase 4 | Status: COMPLETED